YouGov has published a representative survey examining the British public’s attitudes towards cannabis.
In a special edition of the Business of Cannabis Podcast, we go from anecdote to evidence with Dr Anne Katrin Schlag, Head of Research at Drug...
A Freedom of Information request has established that the NHS will publish data from its ‘registry’ by the ‘end of the year’.
By Dr Sue Clenton, Medical Director, Rupa Shah, Chief Legal and Compliance Officer, and Graham Woodward, Chief Operations Officer, Releaf In a healthcare landscape as tightly...
A new clinical trial will investigate the potential of cannabis-based treatment to improve quality of care for hospice eligible patients with dementia.
Research from two separate studies has highlighted how promotional packaging and social media content can make cannabis-infused products more appealing to teens.
Campaigners are urging lawmakers to consider the challenges facing people who rely on access for medical purposes.
In the first controlled clinical trial of CBD in boys with autism, two-thirds of participants showed behavioural improvements with treatment.
The UK’s Food Standards Agency (FSA) has announced some significant updates to its multi-year CBD Novel Foods approvals process.
Words by Dr Sue Clenton, Medical Director, Releaf Over the past year, we’ve seen medical cannabis move from the margins toward the mainstream — not through...
But over half were concerned about the negative impact of stigma associated with cannabis.
